ICU Medical (NASDAQ:ICUI) Upgraded at StockNews.com

ICU Medical (NASDAQ:ICUI) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Tuesday.

ICUI has been the topic of several other research reports. Jefferies Financial Group raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target on the stock in a research report on Wednesday, December 11th. Raymond James set a $97.00 target price on shares of ICU Medical in a research report on Wednesday, March 12th. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $168.67.

ICU Medical Trading Up 2.1 %

Shares of ICUI stock opened at $151.25 on Tuesday. The company’s 50-day moving average price is $156.48 and its 200-day moving average price is $164.65. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The stock has a market cap of $3.71 billion, a price-to-earnings ratio of -33.10 and a beta of 0.73. ICU Medical has a twelve month low of $93.36 and a twelve month high of $196.26.

Insider Transactions at ICU Medical

In other news, CEO Vivek Jain sold 1,373 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total transaction of $213,474.04. Following the sale, the chief executive officer now owns 104,593 shares of the company’s stock, valued at approximately $16,262,119.64. This represents a 1.30 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 6.70% of the company’s stock.

Institutional Trading of ICU Medical

Several hedge funds have recently made changes to their positions in the business. Harvest Fund Management Co. Ltd purchased a new stake in shares of ICU Medical during the fourth quarter worth approximately $33,000. Quarry LP increased its stake in shares of ICU Medical by 764.3% during the fourth quarter. Quarry LP now owns 242 shares of the medical instruments supplier’s stock worth $38,000 after buying an additional 214 shares during the period. Murphy & Mullick Capital Management Corp purchased a new stake in shares of ICU Medical during the fourth quarter worth approximately $52,000. Point72 Hong Kong Ltd purchased a new stake in shares of ICU Medical during the third quarter worth approximately $72,000. Finally, Venturi Wealth Management LLC increased its stake in ICU Medical by 64.0% in the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier’s stock valued at $82,000 after purchasing an additional 206 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.